{
  "docId": "019de073-ed1e-723c-a28e-3c378280574e",
  "docSlug": "3439c61eec2c1805f58a361a1d0fbc84",
  "documentTitle": "ATAI | Investor Presentation Deck | 36 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 36,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a checkmark system to highlight competitive advantages in 'at home use', 'sustained efficacy', and 'rapid onset'.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ed1e-723c-a28e-3c378280574e/18",
  "deckHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e",
  "deckJsonHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e.json",
  "deckAnchorHref": "/decks/019de073-ed1e-723c-a28e-3c378280574e#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Note: 5HT2A-R = Serotonin 2A receptor... Sources: GlobalData, Evaluate Pharma (both as of 2021), Uthaug, M. V. et al. (2019). company websites (1) Rapid onset of treatment effect versus standard of care",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10b02b7a-41ce-4945-9eb1-f3fb485654d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "table",
      "text": "Comparison matrix of TRD treatments including Company, Compound, Potential for at home use, Potential for sustained efficacy, Rapid onset, Mechanism of Action, In-clinic duration, and Distribution channels.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6fb1215-2a87-4b0d-88a0-63c21688d362",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Depression positioning and landscape: atai's programs are designed to be differentiated from one another and from competitors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf48ae52-9f66-4ebf-91be-a3a1d92d8bd8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_table",
      "slug": null,
      "matchId": "a2c21a66-4430-41d1-a9ab-1de8bdf8331c",
      "evidence": "Structured grid comparing attributes across multiple entities.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}